Clinical Trial Update: Real-world Bicohort Observational Study of a Pertuzumab Biosimilar in the Treatment of Breast Cancer: in the Neoadjuvant Setting and in First-line Metastatic Disease

View source ↗

Summary

This clinical trial update describes a real-world bicohort observational study evaluating a pertuzumab biosimilar for breast cancer in the neoadjuvant setting a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pertuzumab biosimilar

Snippet

Sponsor: Société Algérienne de Formation et Recherche en Oncologie | Conditions: Breast Cancer, Her 2 Positive Breast Cancer | Status: RECRUITING